Advertisement

Pediatric Nephrology

, Volume 19, Issue 3, pp 332–336 | Cite as

Soluble adhesion molecules in children and young adults on chronic hemodialysis

  • Kinga Musiał
  • Danuta Zwolińska
  • Dorota Polak-Jonkisz
  • Urszula Berny
  • Krystyna Szprynger
  • Maria Szczepańska
Original Article

Abstract

Children on chronic hemodialysis (HD) present with impaired immunity that may result from disturbances in leukocyte migration, caused by changes in expression of adhesion molecules on endothelium and immunocompetent cells. However, it is still not clear whether the type of dialyzer or a single dialysis session influences the concentrations of soluble adhesion molecules in these patients. We evaluated by ELISA serum levels of soluble (s) VCAM-1, ICAM-1, L-selectin, and P-selectin in 22 patients on cuprophane HD (CU), 8 on polysulfone HD (PS), 10 on vitamin E-modified cellulose HD (VE), and 15 controls. In all HD patients, sVCAM-1 levels were elevated compared with controls and were higher in CU than in VE. The sICAM-1 concentrations were increased in VE compared with controls, but remained unchanged in CU and PS. The sL-selectin levels were reduced in all HD patients. The mean values of sP-selectin were comparable in CU, PS, and controls. The lowest levels were observed in VE. In CU patients, sVCAM-1, sICAM-1, and sP-selectin concentrations rose after HD. A single PS session had no impact on adhesion molecules, whereas a VE session increased the level of sVCAM-1. The type of dialysis membrane may change the profile of adhesion molecule concentrations, thus influencing the immune system of a child on HD. The increase in levels of adhesion molecules in the course of a single HD session, which was pronounced in CU and VE patients, suggests poor biocompatibility of these dialyzers.

Keywords

Adhesion molecules Biocompatibility Hemodialysis Cuprophane Polysulfone Vitamin E-coated membrane 

Notes

Acknowledgements

This work was presented at the World Congress of Nephrology in Berlin in 2003.

References

  1. 1.
    Petruzzelli L, Takami M, Humes HD (1999) Structure and function of cell adhesion molecules. Am J Med 106:467–476CrossRefPubMedGoogle Scholar
  2. 2.
    Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068–2101PubMedGoogle Scholar
  3. 3.
    Pigott R, Dillon LP, Hemingway IH, Gearing AJ (1992) Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187:584–589PubMedGoogle Scholar
  4. 4.
    Leeuwenberg JFM, Smeets EF, Neefjes JJ, Shaffer AA, Cinek T, Jeunhomme TMAA, Ahern TJ, Buurman WA (1992) E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77:543–549PubMedGoogle Scholar
  5. 5.
    Schleiffenbaum B, Spertini O, Tedder TF (1992) Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 119:229–238PubMedGoogle Scholar
  6. 6.
    Kawabata K, Nagake Y, Shikata K, Makino H, Ota Z (1996) The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis. Nephron 73:573–579PubMedGoogle Scholar
  7. 7.
    Gamble JR, Skinner MP, Berndt MC, Vadas MA (1990) Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP-140. Science 249:414–417PubMedGoogle Scholar
  8. 8.
    Combe C, Pourtein M, Precigout V de, Baquey A, Morel D, Potaux L, Vincendeau P, Bezian JH, Aparicio M (1994) Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am J Kidney Dis 24:437–442PubMedGoogle Scholar
  9. 9.
    Dou L, Brunet P, Dignat-George F, Sampol J, Berland Y (1998) Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin. Am J Kidney Dis 31:67–73PubMedGoogle Scholar
  10. 10.
    Himmelfarb J, Zaoui P, Hakim R, Holbrook D (1992) Modulation of granulocyte LAM-1 and MAC-1 during dialysis—a prospective, randomized trial. Kidney Int 41:388–395PubMedGoogle Scholar
  11. 11.
    Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A (1998) Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79:399–407CrossRefPubMedGoogle Scholar
  12. 12.
    Mrowka C, Heintz B, Sieberth HG (1999) Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Clin Nephrol 52:312–321PubMedGoogle Scholar
  13. 13.
    Rabb H, Calderon E, Bittle PA, Ramirez G (1996) Alterations in sICAM-1 and sVCAM-1 in hemodialysis patients. Am J Kidney Dis 27:239–243PubMedGoogle Scholar
  14. 14.
    Thylen P, Fernvik E, Lundahl J, Lins LE, Jacobson SH (1996) Monocyte and granulocyte CD11b/CD18, CD62L expression and sICAM-1 concentration in the interdialytic period. Nephron 74:275–282PubMedGoogle Scholar
  15. 15.
    Zwolińska D, Medyńska A, Szprynger K, Szczepańska M (2000) Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis. Nephron 86:441–446CrossRefPubMedGoogle Scholar
  16. 16.
    Pertosa G, Grandaliano G, Gesualdo L, Schena FP (2000) Clinical relevance of cytokine production in hemodialysis. Kidney Int 58 [Suppl 76]:S104–S111Google Scholar
  17. 17.
    Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot J, Verger C, Dahmane D, Groote D de, Jungers P, Dayer JM (1995) Balance between IL-1β, TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells and monocytes. J Immunol 154:882–892PubMedGoogle Scholar
  18. 18.
    Omata M, Higuchi C, Demura R, Sanaka T, Nihei H (2000) Reduction of neutrophil activation by vitamin E modified dialyzer membranes. Nephron 85:221–231CrossRefPubMedGoogle Scholar
  19. 19.
    Shimazu T, Ominato M, Toyama K, Yasuda T, Sato T, Maeba T, Owada S, Ishida M (2001) Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int 59:S137–S143Google Scholar
  20. 20.
    Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T (1993) Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 151:3267–3273PubMedGoogle Scholar
  21. 21.
    Stuard S, Carreno MP, Poignet JL, Albertazzi A, Heaffner-Cavaillon N (1995) A major role for CD62P/CD15 s interaction in leukocyte margination during hemodialysis. Kidney Int 48:93–102PubMedGoogle Scholar

Copyright information

© IPNA 2004

Authors and Affiliations

  • Kinga Musiał
    • 1
  • Danuta Zwolińska
    • 1
    • 3
  • Dorota Polak-Jonkisz
    • 1
  • Urszula Berny
    • 1
  • Krystyna Szprynger
    • 2
  • Maria Szczepańska
    • 2
  1. 1.Department of Pediatric NephrologyMedical UniversityWrocławPoland
  2. 2.Department of Pediatrics, Clinic of Nephrology, Endocrinology, and Metabolic Diseases of ChildhoodSilesian School of MedicineZabrzePoland
  3. 3.Department of Pediatric NephrologyMedical University WrocławPoland

Personalised recommendations